Humana is a holding company. Through its subsidiaries, Co. is a health and well-being company. Co.'s medical and specialty insurance products allow members to access health care services primarily through its networks of health care providers with whom it has contracted. Co. manages its business with three reportable segments: Retail, which is comprised of products sold on a retail basis to individuals including medical and supplemental benefit plans; Group and Specialty, which consists of employer group commercial fully-insured medical and specialty health insurance benefits; and Healthcare Services, which includes pharmacy, provider, and home services.
When researching a stock like Humana, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from HUM Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for HUM stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of these ways is called the Relative Strength Index, or RSI. This popular indicator, originally developed in the 1970's by J. Welles Wilder, looks at a 14-day moving average of a stock's gains on its up days, versus its losses on its down days. The resulting HUM RSI is a value that measures momentum, oscillating between "oversold" and "overbought" on a scale of zero to 100. A reading below 30 is viewed to be oversold, which a bullish investor could look to as a sign that the selling is in the process of exhausting itself, and look for entry point opportunities. A reading above 70 is viewed to be overbought, which could indicate that a rally in progress is starting to get crowded with buyers. If the rally has been a long one, that could be a sign that a pullback is overdue. |